Next Article in Journal
Pre-Treatment of Platinum Resistant Ovarian Cancer Cells with an MMP-9/MMP-2 Inhibitor Prior to Cisplatin Enhances Cytotoxicity as Determined by High Content Screening
Next Article in Special Issue
Identification and Dynamic Regulation of microRNAs Involved in Salt Stress Responses in Functional Soybean Nodules by High-Throughput Sequencing
Previous Article in Journal
Development of Collagen/Demineralized Bone Powder Scaffolds and Periosteum-Derived Cells for Bone Tissue Engineering Application
Previous Article in Special Issue
Modulation of Cancer Traits by Tumor Suppressor microRNAs
Int. J. Mol. Sci. 2013, 14(1), 2072-2084; doi:10.3390/ijms14012072

Blood microRNAs in Low or No Risk Ischemic Stroke Patients

1 Department of Biochemistry and Neuroscience Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, 8 Medical Drive, 117597, Singapore 2 Department of Medicine, Faculty of Medicine, University Malaya, Kuala Lumpur 50603, Malaysia 3 Department of Biochemistry, Faculty of Medicine, MAHSA University College, 59100 Kuala Lumpur, Malaysia 4 Department of Anatomy and Developmental Biology, School of Biomedical Sciences, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria 3800, Australia These authors contributed equally to this work.
* Author to whom correspondence should be addressed.
Received: 6 November 2012 / Revised: 11 December 2012 / Accepted: 17 January 2013 / Published: 22 January 2013
(This article belongs to the Special Issue Non-Coding RNAs 2012)
View Full-Text   |   Download PDF [492 KB, uploaded 19 June 2014]   |   Browse Figures


Ischemic stroke is a multi-factorial disease where some patients present themselves with little or no risk factors. Blood microRNA expression profiles are becoming useful in the diagnosis and prognosis of human diseases. We therefore investigated the blood microRNA profiles in young stroke patients who presented with minimal or absence of risk factors for stroke such as type 2 diabetes, dyslipidemia and hypertension. Blood microRNA profiles from these patients varied with stroke subtypes as well as different functional outcomes (based on modified Rankin Score). These microRNAs have been shown to target genes that are involved in stroke pathogenesis. The findings from our study suggest that molecular mechanisms in stroke pathogenesis involving low or no risk ischemic stroke patients could differ substantially from those with pre-existing risk factors.
Keywords: stroke; microRNA; etiology; modified Rankin Score stroke; microRNA; etiology; modified Rankin Score
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
MDPI and ACS Style

Tan, J.R.; Tan, K.S.; Koo, Y.X.; Yong, F.L.; Wang, C.W.; Armugam, A.; Jeyaseelan, K. Blood microRNAs in Low or No Risk Ischemic Stroke Patients. Int. J. Mol. Sci. 2013, 14, 2072-2084.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


Cited By

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert